DUBLIN--(BUSINESS WIRE)--The "5-HT1B Agonist - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. 5-HT1B Agonist - Pipeline Insight, 2018 report offers ...
EB-003 revealed to also act as an agonist of the serotonin receptor 5-HT1B, a validated target of drugs approved to treat major depressive disorder and a variety of neurological conditions including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results